Ian T. Clark - 12 Jun 2025 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
Director
Signature
/s/ Leiv Lea, as Attorney-in-Fact for Ian T. Clark
Issuer symbol
CRVS
Transactions as of
12 Jun 2025
Transactions value $
$0
Form type
4
Filing time
16 Jun 2025, 16:27:33 UTC
Previous filing
13 Jun 2025
Next filing
20 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CLARK IAN T Director C/O CORVUS PHARMACEUTICALS, INC., 901 GATEWAY BOULEVARD, THIRD FLOOR, SOUTH SAN FRANCISCO /s/ Leiv Lea, as Attorney-in-Fact for Ian T. Clark 16 Jun 2025 0001336504

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVS Stock Option (Right to Buy) Award $0 +15K $0.00 15K 12 Jun 2025 Common Stock 15K $4.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2026 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.